Charlie Paterson, partner at PA Consulting, explains how reduced FDA capacity and staff turnover have led to longer regulatory timelines, increased preparation for agency interactions, and delayed feedback during early trial planning.
Charlie Paterson
Advertisement
Health and Life Sciences Expert, PA Consulting
Articles by Charlie Paterson
Why future-ready pharma companies must embrace AI-driven, real-time decision-making.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Worldwide Clinical Trials to Acquire Catalyst Clinical Research, Expanding Oncology and FSP Capabilities
2
How Real-World Evidence Will Change Trials Without Replacing Them
3
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
4
ACT Brief: ESG Moves Into Vendor Oversight, RWE Faces Governance Hurdles, and Roche Advances Obesity Pipeline
5